Biolase, Inc. (BIOL) Social Stream



Biolase, Inc. (BIOL): $0.16

0.03 (-14.32%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

BIOLASE INC (BIOL) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering BIOL.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-03-18 1 $2 $2 $2 $1.21 65.29%
2022-03-22 1 $2.001 $2 $2 $1.21 65.29%
2022-04-08 1 $50 $37.5 $43.75 $1.21 3515.7%
2022-06-03 3 $25 $10 $17.5 $1.21 1346.28%
2022-11-18 3 $25 $5 $14 $1.21 1057.02%
2023-04-06 3 $12 $1 $5 $1.21 313.22%
2023-05-31 2 $2 $0.4 $1.133 $1.21 -6.36%
2023-06-09 2 $2 $0.3 $0.9 $1.21 -25.62%
2023-09-08 2 $200 $30 $90 $1.21 7338.02%
2023-09-20 2 $40 $4 $24.666 $1.21 1938.51%
2023-10-02 2 $40 $4 $16.333 $1.21 1249.83%
2023-11-15 2 $40 $3 $15.666 $1.21 1194.71%
2023-12-08 3 $40 $3 $15.666 $1.21 1194.71%

The Trend in the Analyst Price Target


Over the past 44 months, BIOL's average price target has gone up $13.29.

BIOL reports an average of 8,320.29% for its upside potential over the past 36 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-04-06 3 12 1 5.000 0.28 1685.71%
2023-04-06 1 2 1 1.500 0.28 435.71%
2023-10-02 2 40 4 16.333 1.89 764.18%
2023-11-15 3 40 3 15.666 1.27 1133.54%
2023-12-08 3 40 3 15.666 1.13 1286.37%

BIOL Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 3 0 0 0 0 3

The Trend in the Broker Recommendations


Over the past 26 weeks, BIOL's average broker recommendation rating improved by 0.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In terms of how BIOLASE INC fares relative to all US stocks, note that its number of analysts covering the stock is greater than 72.74% of that group.
  • In terms of how BIOLASE INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -1346.83% of that group.
  • In the context of Medical Equipment stocks, BIOLASE INC's average analyst price target is greater than 335.02% of them.
  • To contextualize these metrics, consider that out of Medical Equipment stocks, BIOLASE INC's upside potential (average analyst target price relative to current price) is greater than 1566.78% of them.

Stocks similar to BIOLASE INC in the Medical Equipment industry regarding analyst recommendations and price targets are RXST, HYPR, and RWLK.

Is BIOL a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!